AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-30739943_ITM" title="Facts and information about In case you haven't heard ...(AstraZeneca's antipsychotic drug Seroquel sales rose)(Brief article)">In case you haven't heard ...(AstraZeneca's antipsychotic drug Seroquel sales rose)(Brief article)</a>
Close
Set up an RSS feed that alerts you when new articles from Mental Health Weekly are available.
Frequently asked questions about RSS feeds
In case you haven't heard ...(AstraZeneca's antipsychotic drug Seroquel sales rose)(Brief article)
In late October, the Food and Drug Administration (FDA) approved a new antidepressant indication for AstraZeneca's antipsychotic drug Seroquel (quetiapine), making it the first single medicine approved to treat both the manic and depressive symptoms of bipolar disorder. Investor's Business Daily reported (Nov. 3) that next year, the drug maker will apply for bipolar …
Related articles from newspapers, magazines, journals, and more
-
- DR REDDY'S TO LAUNCH GENERIC ANTIPSYCHOTIC DRUG IN US MARKET (as AstraZeneca...
-
Magazine article from: India Business Insight
March 31, 2012
700+ words
-
- AstraZeneca Sales Tumble 18% in Second Quarter
-
News wire article from: Europe Intelligence Wire
July 26, 2012
700+ words
-
- Woodford Top Holding AstraZeneca Sees Sales Drop 21%
-
News wire article from: Europe Intelligence Wire
July 26, 2012
700+ words
-
- AstraZeneca Appoints New Chief Executive
-
News wire article from: Europe Intelligence Wire
August 28, 2012
700+ words
-
- Largest civil settlement in pharmaceutical case announced by US Department of...
-
News wire article from: Chemical Business Newsbase
April 27, 2010
700+ words
